Enrolling Studies

Browse our currently enrolling clinical trials, learn about past research, and see what's coming next. If a study matches your situation, our team will guide you through the next steps.

Participant Information

Why participate in clinical research?

Joining a clinical trial is an opportunity to help advance medical science and gain access to the best healthcare. Clinical research studies are conducted to help evaluate and advance new treatment options, drugs, and other interventions that may benefit patients and communities.

At CPCC Research, the safety, comfort, and well-being of our participants are our top priority. Every clinical trial is conducted according to the highest ethical and regulatory standards, ensuring your rights are protected throughout the clinical trial.

Access to New Treatments: Receive access to new and experimental treatments that are not yet widely available.
Expert Medical Care: Receive the best and closest medical care and attention from experienced and skilled healthcare professionals.
Contribute to Medical Advancement: Contribute to the advancement of medical science and help future patients.
Support Inclusive Research: Help ensure that research is conducted among diverse communities.

Currently Enrolling

Current Studies

These trials are actively enrolling participants. Click any study to view the full details, sponsor information, and contact our team.

Enrolling Now

COPD · Phase 2

Pfizer COPD Umbrella Study

Sponsored by Pfizer. This adaptive study evaluates two different investigational drugs (PF-07275315 and PF-07264660) against a common placebo in participants...

C4531031

Enrolling Now

COPD · Phase 3

EMBARK — Tezepelumab for COPD

Sponsored by AstraZeneca. This study evaluates the efficacy and safety of tezepelumab in adults with moderate-to-severe COPD who continue to experience exacerbations...

D5241C00006

Enrolling Now

COPD · Phase 3

ENDURA-2 — Depemokimab for COPD

Sponsored by GlaxoSmithKline (GSK). To determine if Depemokimab reduces the rate of moderate/severe exacerbations compared to placebo.

222725

Enrolling Now

RSV · Phase 2b

RSV Study

Sponsored by Shionogi. To investigate the PK of S-337395 in participants with RSV infection.

2402T1432

Enrolling Now

Asthma · Phase 2b

Uncontrolled Moderate to Severe Eosinophilic Asthma

Sponsored by Kymera Therapeutics, Inc.. To evaluate the efficacy of multiple doses of KT-621 compared to placebo in participants with uncontrolled moderate to severe eosinophilic...

KT621-AS-202

Enrolling Now

Asthma · Phase 2

Moderate to Severe Asthma — Pfizer

Sponsored by Pfizer Inc.. The purpose of the study is to evaluate the efficacy and safety of PF-07275315 in participants with inadequately controlled...

C4531029

Enrolling Now

COPD · Phase 2

COPD — ZION Study

Sponsored by Uniquity One. To assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of solrikitug 375 mg every 4 weeks (Q4W) on blood eosinophil...

NSI-8226-205

Coming Soon

Upcoming Trials

New trials we're preparing to launch. Contact us to be notified when enrollment opens.

Upcoming

ALTESA — Vapendavir for COPD with Rhinovirus

Sponsored by Altesa BioSciences, Inc. · COPD

Study ID: ALT-VPV-203

Upcoming

AERIFY-5 — Itepekimab for COPD

KT-621 Long-Term Extension for Asthma

Sponsored by Kymera Therapeutics, Inc. · Asthma

Study ID: KT621-AS-203

Completed Research

Past Studies

Past studies are in maintenance or pre–close-out phase (not enrolling; subjects may still be in treatment).

EXHALE-3

SponsorAreteia Therapeutics

IndicationAsthma

Study IDAR-DEX-22-02

EXHALE-4

SponsorAreteia Therapeutics

IndicationAsthma

Study IDAR-DEX-22-03

PILLAR

SponsorChiesi

IndicationAsthma

Study IDCLI-06001AA1-05

AJAX

SponsorAstraZeneca

IndicationAsthma

Study IDD8210C00003

MIRANDA

SponsorAstraZeneca

IndicationAsthma

Study IDD9180C00012

AERIFY-4

SponsorSanofi

IndicationAsthma

Study IDLTS18133

INCB-54707-208

SponsorIncyte

IndicationAsthma

Study IDINCB-54707-208

EDP938-104

SponsorEnanta Pharmaceuticals

IndicationRSV

Study IDEDP938-104

AERIFY-1

SponsorSanofi

IndicationCOPD

Study IDEFC16750

Apollo

SponsorPrognomiQ, Inc

IndicationLung Cancer Screening

Study IDP-030101

RAINIER

SponsorUniquity One

IndicationAsthma

Study IDNSI-8226-204

Ready to Participate

Not sure which study fits you?

Our research coordinators will reach out to discuss your options. All information is confidential, and there's no obligation to participate.

Apply Online Call 404-254-5388